Literature DB >> 17662095

Comparison of a bupivacaine 0.5% and lidocaine 2% mixture with levobupivacaine 0.75% and ropivacaine 1% in peribulbar anaesthesia for cataract surgery with phacoemulsification.

Mehmet Borazan1, Aylin Karalezli, Sibel Oto, Cengiz Algan, Yonca Aydin Akova.   

Abstract

PURPOSE: To compare a bupivacaine and lidocaine mixture with levobupivacaine and ropivacaine in terms of safety, efficacy and blocking quality in peribulbar anaesthesia for phacoemulsification.
METHODS: A total of 105 patients scheduled for cataract surgery with peribulbar anaesthesia were randomly allocated into three groups of 35 patients each, to receive 5 ml of, respectively, a 1 : 1 mixture of bupivacaine 0.5% and lidocaine 2% (group 1), levobupivacaine 0.75% (group 2), or ropivacaine 1% (group 3). Ocular movement scores were evaluated at 2, 4, 6, 8 and 10 mins after injection. Intraoperative and postoperative analgesia were evaluated by verbal pain scores. Duration of surgery, need for supplementary anaesthesia, haemodynamic parameters and the incidence of perioperative complications were recorded.
RESULTS: The ocular movement score in min 2 was significantly lower in group 1. There was no significant difference between groups 2 and 3. Ocular movement scores at mins 4 and 6 were significantly decreased in group 1 and 2 compared with group 3. There was no significant difference among the groups in ocular movement scores at mins 8 and 10. Verbal pain scores in postoperative hour 4 were highest in group 3, but scores for the intraoperative period and postoperative hours 1 and 2 were similar among the groups. Duration of surgery and haemodynamic parameters did not differ among the groups.
CONCLUSIONS: All agents were considered to be convenient for clinical use in cataract surgery with peribulbar anaesthesia. Although the ocular movement scores in the ropivacaine group were higher than in the other groups at mins 4 and 6, this did not imply any clinical significance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662095     DOI: 10.1111/j.1600-0420.2007.00976.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  8 in total

Review 1.  Anaesthesia for cataract surgery.

Authors:  Emmanuel Nouvellon; Philippe Cuvillon; Jacques Ripart; Eric J Viel
Journal:  Drugs Aging       Date:  2010-01-01       Impact factor: 3.923

2.  Cataract surgery complications: an in vitro model of toxic effects of ropivacaine and lidocaine.

Authors:  Nicola Pescosolido; Gianfranco Scarsella; Marco Tafani; Marcella Nebbioso
Journal:  Drugs R D       Date:  2011-12-01

3.  The efficacy of 0.75% levobupivacaine versus 0.75% ropivacaine for peribulbar anesthesia in vitreoretinal surgery.

Authors:  Ashraf M Ghali
Journal:  Saudi J Anaesth       Date:  2012-01

4.  The quest for effective pain control during suture adjustment after strabismus surgery: a study evaluating supplementation of 2% lidocaine with 0.4% ropivacaine.

Authors:  Howard D Palte; Kara M Cavuoto; Lalitha Sundararaman; Steven Gayer; Joyce Schiffman; Hilda Capo
Journal:  J Pain Res       Date:  2015-01-14       Impact factor: 3.133

5.  Comparison of levobupivacaine 0.5% or bupivacaine 0.5% both in a mixture with lidocaine 2% for superficial extraconal blockade.

Authors:  Nauman Ahmad; Abdul Zahoor; Abdullah Al Assiri; Sabah Al Jastaneiah; Waleed Riad
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Jul-Sep

6.  Efficacy and safety of 0.5% levobupivacaine versus 0.5% bupivacaine for peribulbar anesthesia.

Authors:  Elena Pacella; Fernanda Pacella; Fabiana Troisi; Domenico Dell'edera; Paolo Tuchetti; Tommaso Lenzi; Saul Collini
Journal:  Clin Ophthalmol       Date:  2013-05-21

Review 7.  Update on the clinical utility and practical use of ropivacaine in Chinese patients.

Authors:  Man Li; Li Wan; Wei Mei; Yuke Tian
Journal:  Drug Des Devel Ther       Date:  2014-09-09       Impact factor: 4.162

8.  Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats.

Authors:  Cristina A Lelescu; Andrada E Urdă-Cîmpean; Daria A Dumitraș; Marian Taulescu; Cosmin Mureșan
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.